{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:18Z","timestamp":1792190598685,"version":"4.4.0"},"reference-count":308,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902729"],"award-info":[{"award-number":["81902729"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Funding for the Construction of Innovative Provinces in Hunan","award":["2020SK4003"],"award-info":[{"award-number":["2020SK4003"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2021T140749"],"award-info":[{"award-number":["2021T140749"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2020JJ4925"],"award-info":[{"award-number":["2020JJ4925"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project Program of National Clinical Research Center for Geriatric Disorders","award":["2021KFJJ03"],"award-info":[{"award-number":["2021KFJJ03"]}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["CX20210354"],"award-info":[{"award-number":["CX20210354"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Thyroid cancer as one of the most prevalent malignancies of endocrine system, has raised public concern and more research on its mechanism and treatment. And metabolism-based therapies have advanced rapidly, for the exclusive metabolic profiling of thyroid cancer. In thyroid cancer cells, plenty of metabolic pathways are reprogrammed to accommodate tumor microenvironment. In this review, we initiatively summarize recent progress in the full-scale thyroid cancer metabolic rewiring and the interconnection of various metabolites. We also discuss the efficacy and prospect of metabolic targeted detection as well as therapy. Comprehending metabolic mechanism and characteristics of thyroid cancer roundly will be highly beneficial to managing individual patients.<\/jats:p>","DOI":"10.1186\/s12943-025-02263-4","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:13:44Z","timestamp":1741670024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuxuan","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saili","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2263_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/iub.1563","volume":"68","author":"L Xu","year":"2016","unstructured":"Xu L, Ren H, Gao G, Zhou L, Malik MA, Li P. The progress and challenges in metabolic research in China. IUBMB Life. 2016;68:847\u201353.","journal-title":"IUBMB Life"},{"key":"2263_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/EBC20190041","volume":"64","author":"A Judge","year":"2020","unstructured":"Judge A, Dodd MS. Metabolism. Essays Biochem. 2020;64:607\u201347.","journal-title":"Essays Biochem"},{"key":"2263_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.clinbiochem.2013.04.027","volume":"46","author":"M Dashty","year":"2013","unstructured":"Dashty M. A quick look at biochemistry: carbohydrate metabolism. Clin Biochem. 2013;46:1339\u201352.","journal-title":"Clin Biochem"},{"key":"2263_CR4","doi-asserted-by":"publisher","first-page":"e13131","DOI":"10.1111\/obr.13131","volume":"22","author":"JE Galgani","year":"2021","unstructured":"Galgani JE, Fern\u00e1ndez-Verdejo R. Pathophysiological role of metabolic flexibility on metabolic health. Obes Rev Off J Int Assoc Study Obes. 2021;22:e13131.","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"2263_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s11427-019-1563-3","volume":"62","author":"L Chen","year":"2019","unstructured":"Chen L, Chen X-W, Huang X, Song B-L, Wang Y, Wang Y. Regulation of glucose and lipid metabolism in health and disease. Sci China Life Sci. 2019;62:1420\u201358.","journal-title":"Sci China Life Sci"},{"key":"2263_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"PJ Magistretti","year":"2015","unstructured":"Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86:883\u2013901.","journal-title":"Neuron"},{"key":"2263_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41582-022-00651-8","volume":"18","author":"JM Rho","year":"2022","unstructured":"Rho JM, Boison D. The metabolic basis of epilepsy. Nat Rev Neurol. 2022;18:333\u201347.","journal-title":"Nat Rev Neurol"},{"key":"2263_CR8","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms23073785","volume":"23","author":"CG Ardanaz","year":"2022","unstructured":"Ardanaz CG, Ram\u00edrez MJ, Solas M. Brain Metabolic Alterations in Alzheimer\u2019s Disease. Int J Mol Sci. 2022;23:3785.","journal-title":"Int J Mol Sci"},{"key":"2263_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","volume":"2","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves M, Spriet LL. Skeletal muscle energy metabolism during exercise. Nat Metab. 2020;2:817\u201328.","journal-title":"Nat Metab"},{"key":"2263_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2263_CR11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","volume":"186","author":"LWS Finley","year":"2023","unstructured":"Finley LWS. What is cancer metabolism? Cell. 2023;186:1670\u201388.","journal-title":"Cell"},{"key":"2263_CR12","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1016\/j.molcel.2021.06.021","volume":"81","author":"JS Brunner","year":"2021","unstructured":"Brunner JS, Finley LWS. SnapShot: Cancer metabolism. Mol Cell. 2021;81:3878\u20133878.e1.","journal-title":"Mol Cell"},{"key":"2263_CR13","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1016\/j.molcel.2021.08.026","volume":"81","author":"V Papalazarou","year":"2021","unstructured":"Papalazarou V, Maddocks ODK. Supply and demand: Cellular nutrient uptake and exchange in cancer. Mol Cell. 2021;81:3731\u201348.","journal-title":"Mol Cell"},{"key":"2263_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17:351\u20139.","journal-title":"Nat Cell Biol"},{"key":"2263_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9:225\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2263_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinol Metab Clin North Am. 2019;48:23\u201335.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2263_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33:27\u201363.","journal-title":"Endocr Pathol"},{"key":"2263_CR18","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0293","volume":"30","author":"C Christofer Juhlin","year":"2023","unstructured":"Christofer Juhlin C, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 2023;30: e220293.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-med-061512-105739","volume":"65","author":"T Carling","year":"2014","unstructured":"Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014;65:125\u201337.","journal-title":"Annu Rev Med"},{"key":"2263_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10:264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2263_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1089\/thy.2020.0322","volume":"31","author":"C Dierks","year":"2021","unstructured":"Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, et al. Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma. Thyroid Off J Am Thyroid Assoc. 2021;31:1076\u201385.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CCO.0b013e328011ab86","volume":"19","author":"VV Vasko","year":"2007","unstructured":"Vasko VV, Saji M. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr Opin Oncol. 2007;19:11\u20137.","journal-title":"Curr Opin Oncol"},{"key":"2263_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","volume":"381","author":"M Xing","year":"2013","unstructured":"Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer. Lancet Lond Engl. 2013;381:1058\u201369.","journal-title":"Lancet Lond Engl"},{"key":"2263_CR24","doi-asserted-by":"publisher","first-page":"1126913","DOI":"10.3389\/fonc.2022.1126913","volume":"12","author":"B Kaur","year":"2023","unstructured":"Kaur B, Sohrabi Y, Achreja A, Lisanti MP, Martinez-Outschoorn UE. Editorial: Hallmark of cancer: Reprogramming of cellular metabolism. Front Oncol. 2023;12:1126913.","journal-title":"Front Oncol"},{"key":"2263_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2263_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"2263_CR27","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3390\/cancers12102819","volume":"12","author":"RM Pascale","year":"2020","unstructured":"Pascale RM, Calvisi DF, Simile MM, Feo CF, Feo F. The Warburg Effect 97 Years after Its Discovery. Cancers. 2020;12:2819.","journal-title":"Cancers"},{"key":"2263_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"2263_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/ijms23031155","volume":"23","author":"J Gyamfi","year":"2022","unstructured":"Gyamfi J, Kim J, Choi J. Cancer as a Metabolic Disorder. Int J Mol Sci. 2022;23:1155.","journal-title":"Int J Mol Sci"},{"key":"2263_CR30","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism Sci Adv. 2016;2: e1600200.","journal-title":"Fundamentals of cancer metabolism Sci Adv"},{"key":"2263_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-77736-8_1","volume":"1063","author":"S Bose","year":"2018","unstructured":"Bose S, Le A. Glucose Metabolism in Cancer. Adv Exp Med Biol. 2018;1063:3\u201312.","journal-title":"Adv Exp Med Biol"},{"key":"2263_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"2263_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ. Understanding the Intersections between Metabolism and Cancer Biology. Cell. 2017;168:657\u201369.","journal-title":"Cell"},{"key":"2263_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/s12967-023-04617-2","volume":"21","author":"S-L Duan","year":"2023","unstructured":"Duan S-L, Wu M, Zhang Z-J, Chang S. The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer. J Transl Med. 2023;21:735.","journal-title":"J Transl Med"},{"key":"2263_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356:156\u201364.","journal-title":"Cancer Lett"},{"key":"2263_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2014.08.027","volume":"79","author":"X Chen","year":"2015","unstructured":"Chen X, Qian Y, Wu S. The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med. 2015;79:253\u201363.","journal-title":"Free Radic Biol Med"},{"key":"2263_CR37","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95:912\u20139.","journal-title":"Int J Radiat Biol"},{"key":"2263_CR38","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.3390\/ijms20235898","volume":"20","author":"B Liz\u00e1k","year":"2019","unstructured":"Liz\u00e1k B, Szarka A, Kim Y, Choi K-S, N\u00e9meth CE, Marcolongo P, et al. Glucose Transport and Transporters in the Endomembranes. Int J Mol Sci. 2019;20:5898.","journal-title":"Int J Mol Sci"},{"key":"2263_CR39","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1111\/febs.14577","volume":"285","author":"P-B Ancey","year":"2018","unstructured":"Ancey P-B, Contat C, Meylan E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J. 2018;285:2926\u201343.","journal-title":"FEBS J"},{"key":"2263_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","volume":"34","author":"M Mueckler","year":"2013","unstructured":"Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34:121\u201338.","journal-title":"Mol Aspects Med"},{"key":"2263_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13000-023-01377-x","volume":"18","author":"B Li","year":"2023","unstructured":"Li B. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma. Diagn Pathol. 2023;18:88.","journal-title":"Diagn Pathol"},{"key":"2263_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.apsb.2019.12.005","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang J. Targeting uptake transporters for cancer imaging and treatment. Acta Pharm Sin B. 2020;10:79\u201390.","journal-title":"Acta Pharm Sin B"},{"key":"2263_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12964-020-00586-x","volume":"18","author":"S Heydarzadeh","year":"2020","unstructured":"Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal CCS. 2020;18:83.","journal-title":"Cell Commun Signal CCS"},{"key":"2263_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.surg.2016.04.050","volume":"161","author":"YJ Chai","year":"2017","unstructured":"Chai YJ, Yi JW, Oh SW, Kim YA, Yi KH, Kim JH, et al. Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas. Surgery. 2017;161:188\u201394.","journal-title":"Surgery"},{"key":"2263_CR45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fonc.2020.00956","volume":"10","author":"W Yang","year":"2020","unstructured":"Yang W, Zheng Z, Yi P, Wang S, Zhang N, Ming J, et al. LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling. Front Oncol. 2020;10:956.","journal-title":"Front Oncol"},{"key":"2263_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang J, Sun W, Wang Z, Lv C, Zhang T, Zhang D, et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J Exp Clin Cancer Res CR. 2022;41:42.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1530\/JME-14-0118","volume":"53","author":"F Morani","year":"2014","unstructured":"Morani F, Phadngam S, Follo C, Titone R, Aimaretti G, Galetto A, et al. PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. J Mol Endocrinol. 2014;53:247\u201358.","journal-title":"J Mol Endocrinol"},{"key":"2263_CR48","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2147\/OTT.S194256","volume":"12","author":"W Yu","year":"2019","unstructured":"Yu W, Yang Z, Huang R, Min Z, Ye M. SIRT6 promotes the Warburg effect of papillary thyroid cancer cell BCPAP through reactive oxygen species. OncoTargets Ther. 2019;12:2861\u20138.","journal-title":"OncoTargets Ther"},{"key":"2263_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12935-019-0730-4","volume":"19","author":"Z Yang","year":"2019","unstructured":"Yang Z, Yu W, Huang R, Ye M, Min Z. SIRT6\/HIF-1\u03b1 axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition. Cancer Cell Int. 2019;19:17.","journal-title":"Cancer Cell Int"},{"key":"2263_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mce.2016.06.013","volume":"434","author":"C-T Shen","year":"2016","unstructured":"Shen C-T, Wei W-J, Qiu Z-L, Song H-J, Luo Q-Y. Afamin promotes glucose metabolism in papillary thyroid carcinoma. Mol Cell Endocrinol. 2016;434:108\u201315.","journal-title":"Mol Cell Endocrinol"},{"key":"2263_CR51","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1210\/jc.2006-2707","volume":"92","author":"C Durante","year":"2007","unstructured":"Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, et al. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab. 2007;92:2840\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR52","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1089\/thy.2012.0546","volume":"23","author":"BH Kim","year":"2013","unstructured":"Kim BH, Lee CH, Kim S-J, Jeon YK, Kim SS, Kim YK, et al. Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy. Thyroid Off J Am Thyroid Assoc. 2013;23:1431\u20136.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR53","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.2147\/OTT.S227291","volume":"13","author":"C Yang","year":"2020","unstructured":"Yang C, Xu W, Gong J, Chai F, Cui D, Liu Z. Six1 Overexpression Promotes Glucose Metabolism and Invasion Through Regulation of GLUT3, MMP2 and Snail in Thyroid Cancer Cells. OncoTargets Ther. 2020;13:4855\u201363.","journal-title":"OncoTargets Ther"},{"key":"2263_CR54","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.7150\/ijbs.72397","volume":"18","author":"X Zhu","year":"2022","unstructured":"Zhu X, Xue C, Kang X, Jia X, Wang L, Younis MH, et al. DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis. Int J Biol Sci. 2022;18:4372\u201387.","journal-title":"Int J Biol Sci"},{"key":"2263_CR55","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.21037\/gs-21-481","volume":"10","author":"W Chen","year":"2021","unstructured":"Chen W, Zhang T, Bai Y, Deng H, Yang F, Zhu R, et al. Upregulated circRAD18 promotes tumor progression by reprogramming glucose metabolism in papillary thyroid cancer. Gland Surg. 2021;10:2500\u201310.","journal-title":"Gland Surg"},{"key":"2263_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.829009","volume":"13","author":"L Jin","year":"2022","unstructured":"Jin L, Zheng D, Mo D, Guan Y, Wen J, Zhang X, et al. Glucose-to-Lymphocyte Ratio (GLR) as a Predictor of Preoperative Central Lymph Node Metastasis in Papillary Thyroid Cancer Patients With Type 2 Diabetes Mellitus and Construction of the Nomogram. Front Endocrinol. 2022;13: 829009.","journal-title":"Front Endocrinol"},{"key":"2263_CR57","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","volume":"23","author":"A Fukushi","year":"2022","unstructured":"Fukushi A, Kim H-D, Chang Y-C, Kim C-H. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells. Int J Mol Sci. 2022;23:10037.","journal-title":"Int J Mol Sci"},{"key":"2263_CR58","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.7150\/jca.30018","volume":"10","author":"C-L Liu","year":"2019","unstructured":"Liu C-L, Yang P-S, Wang T-Y, Huang S-Y, Kuo Y-H, Cheng S-P. PGC1\u03b1 downregulation and glycolytic phenotype in thyroid cancer. J Cancer. 2019;10:3819\u201329.","journal-title":"J Cancer"},{"key":"2263_CR59","doi-asserted-by":"publisher","first-page":"C617","DOI":"10.1152\/ajpcell.00218.2022","volume":"323","author":"L Li","year":"2022","unstructured":"Li L, Wang M, Ma Q, Ye J, Sun G. Role of glycolysis in the development of atherosclerosis. Am J Physiol Cell Physiol. 2022;323:C617\u201329.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2263_CR60","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ijc.29564","volume":"138","author":"E Saunier","year":"2016","unstructured":"Saunier E, Benelli C, Bortoli S. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents. Int J Cancer. 2016;138:809\u201317.","journal-title":"Int J Cancer"},{"key":"2263_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gendis.2017.02.003","volume":"4","author":"B Jiang","year":"2017","unstructured":"Jiang B. Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis. 2017;4:25\u20137.","journal-title":"Genes Dis"},{"key":"2263_CR62","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00421-017-3795-6","volume":"118","author":"BS Ferguson","year":"2018","unstructured":"Ferguson BS, Rogatzki MJ, Goodwin ML, Kane DA, Rightmire Z, Gladden LB. Lactate metabolism: historical context, prior misinterpretations, and current understanding. Eur J Appl Physiol. 2018;118:691\u2013728.","journal-title":"Eur J Appl Physiol"},{"key":"2263_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.218","volume":"4","author":"S Nong","year":"2023","unstructured":"Nong S, Han X, Xiang Y, Qian Y, Wei Y, Zhang T, et al. Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm. 2023;4: e218.","journal-title":"MedComm"},{"key":"2263_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2014.07.019","volume":"92","author":"MO Warmoes","year":"2014","unstructured":"Warmoes MO, Locasale JW. Heterogeneity of glycolysis in cancers and therapeutic opportunities. Biochem Pharmacol. 2014;92:12\u201321.","journal-title":"Biochem Pharmacol"},{"key":"2263_CR65","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tcb.2022.02.003","volume":"32","author":"X Bian","year":"2022","unstructured":"Bian X, Jiang H, Meng Y, Li Y-P, Fang J, Lu Z. Regulation of gene expression by glycolytic and gluconeogenic enzymes. Trends Cell Biol. 2022;32:786\u201399.","journal-title":"Trends Cell Biol"},{"key":"2263_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res CR. 2020;39:126.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144681","volume":"750","author":"J Huang","year":"2020","unstructured":"Huang J, Gao W, Liu H, Yin G, Duan H, Huang Z, et al. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT\/mTOR\/HK2-mediated glycolysis. Gene. 2020;750: 144681.","journal-title":"Gene"},{"key":"2263_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12885-015-1135-y","volume":"15","author":"P Kachel","year":"2015","unstructured":"Kachel P, Trojanowicz B, Sekulla C, Prenzel H, Dralle H, Hoang-Vu C. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue. BMC Cancer. 2015;15:140.","journal-title":"BMC Cancer"},{"key":"2263_CR69","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.15772","volume":"114","author":"X Ji","year":"2023","unstructured":"Ji X, Lv C, Huang J, Dong W, Sun W, Zhang H. ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Sci. 2023;114:2318\u201334.","journal-title":"Cancer Sci"},{"key":"2263_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116877","volume":"239","author":"J Chen","year":"2019","unstructured":"Chen J, Zhou Q, Feng J, Zheng W, Du J, Meng X, et al. Activation of AMPK promotes thyroid cancer cell migration through its interaction with PKM2 and \u03b2-catenin. Life Sci. 2019;239: 116877.","journal-title":"Life Sci"},{"key":"2263_CR71","first-page":"1793","volume":"10","author":"G Yu","year":"2018","unstructured":"Yu G, Sun W, Shen Y, Hu Y, Liu H, Li W, et al. PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis. Am J Transl Res. 2018;10:1793\u2013801.","journal-title":"Am J Transl Res"},{"key":"2263_CR72","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1210\/jc.2012-4258","volume":"98","author":"C Feng","year":"2013","unstructured":"Feng C, Gao Y, Wang C, Yu X, Zhang W, Guan H, et al. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98:E1524\u20131533.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR73","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.2147\/OTT.S253137","volume":"13","author":"B Liu","year":"2020","unstructured":"Liu B, Song M, Qin H, Zhang B, Liu Y, Sun Y, et al. Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2. OncoTargets Ther. 2020;13:7629\u201339.","journal-title":"OncoTargets Ther"},{"key":"2263_CR74","first-page":"9","volume":"7","author":"MC van der Heijden","year":"1986","unstructured":"van der Heijden MC, Verhagen JN, Rijksen G, der Kinderen PJ, van Unnik JA, Staal GE. Phosphofructokinase in normal thyroid tissue and thyroid neoplasms. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 1986;7:9\u201318.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"2263_CR75","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","volume":"34","author":"E Enzo","year":"2015","unstructured":"Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, et al. Aerobic glycolysis tunes YAP\/TAZ transcriptional activity. EMBO J. 2015;34:1349\u201370.","journal-title":"EMBO J"},{"issue":"134","key":"2263_CR76","first-page":"529","volume":"2023","author":"GA Brooks","year":"1985","unstructured":"Brooks GA, Osmond AD, Arevalo JA, Duong JJ, Curl CC, Moreno-Santillan DD, et al. Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism. J Appl Physiol Bethesda Md. 1985;2023(134):529\u201348.","journal-title":"J Appl Physiol Bethesda Md"},{"key":"2263_CR77","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7:305.","journal-title":"Signal Transduct Target Ther"},{"key":"2263_CR78","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3892\/ijmm.2015.2368","volume":"36","author":"M Chen","year":"2015","unstructured":"Chen M, Shen M, Li Y, Liu C, Zhou K, Hu W, et al. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. Int J Mol Med. 2015;36:1607\u201314.","journal-title":"Int J Mol Med"},{"issue":"181","key":"2263_CR79","first-page":"166","volume":"2023","author":"TBS Miholjcic","year":"1990","unstructured":"Miholjcic TBS, Halse H, Bonvalet M, Bigorgne A, Rouanne M, Dercle L, et al. Rationale for LDH-targeted cancer immunotherapy. Eur J Cancer Oxf Engl. 1990;2023(181):166\u201378.","journal-title":"Eur J Cancer Oxf Engl"},{"key":"2263_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13577-021-00622-z","volume":"35","author":"X Wang","year":"2022","unstructured":"Wang X, Liu H, Ni Y, Shen P, Han X. Lactate shuttle: from substance exchange to regulatory mechanism. Hum Cell. 2022;35:1\u201314.","journal-title":"Hum Cell"},{"key":"2263_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102065","volume":"46","author":"M Ying","year":"2021","unstructured":"Ying M, You D, Zhu X, Cai L, Zeng S, Hu X. Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions. Redox Biol. 2021;46: 102065.","journal-title":"Redox Biol"},{"key":"2263_CR82","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123:3685\u201392.","journal-title":"J Clin Invest"},{"key":"2263_CR83","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antib10030025","volume":"10","author":"VY Tu","year":"2021","unstructured":"Tu VY, Ayari A, O\u2019Connor RS. Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer. Antibodies Basel Switz. 2021;10:25.","journal-title":"Antibodies Basel Switz"},{"key":"2263_CR84","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fonc.2020.00231","volume":"10","author":"F Baltazar","year":"2020","unstructured":"Baltazar F, Afonso J, Costa M, Granja S. Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy. Front Oncol. 2020;10:231.","journal-title":"Front Oncol"},{"key":"2263_CR85","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0344","volume":"30","author":"X Wang","year":"2023","unstructured":"Wang X, Ying T, Yuan J, Wang Y, Su X, Chen S, et al. BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation. Endocr Relat Cancer. 2023;30: e220344.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966457","volume":"13","author":"Y Song","year":"2022","unstructured":"Song Y, Liu X, Stielow JB, de Hoog S, Li R. Post-translational changes in Phialophora verrucosa via lysine lactylation during prolonged presence in a patient with a CARD9-related immune disorder. Front Immunol. 2022;13: 966457.","journal-title":"Front Immunol"},{"key":"2263_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.594743","volume":"11","author":"M Gao","year":"2020","unstructured":"Gao M, Zhang N, Liang W. Systematic Analysis of Lysine Lactylation in the Plant Fungal Pathogen Botrytis cinerea. Front Microbiol. 2020;11: 594743.","journal-title":"Front Microbiol"},{"key":"2263_CR88","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41419-021-03641-8","volume":"12","author":"X Hou","year":"2021","unstructured":"Hou X, Shi X, Zhang W, Li D, Hu L, Yang J, et al. LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma. Cell Death Dis. 2021;12:347.","journal-title":"Cell Death Dis"},{"key":"2263_CR89","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone A, Prigione A, Cramer T, Wamelink MMC, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc. 2015;90:927\u201363.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"2263_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000519784","volume":"66","author":"N Ghanem","year":"2021","unstructured":"Ghanem N, El-Baba C, Araji K, El-Khoury R, Usta J, Darwiche N. The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities. Chemotherapy. 2021;66:179\u201391.","journal-title":"Chemotherapy"},{"key":"2263_CR91","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell. 2014;5:592\u2013602.","journal-title":"Protein Cell"},{"key":"2263_CR92","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/cells8091055","volume":"8","author":"H-C Yang","year":"2019","unstructured":"Yang H-C, Wu Y-H, Yen W-C, Liu H-Y, Hwang T-L, Stern A, et al. The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer. Cells. 2019;8:1055.","journal-title":"Cells"},{"key":"2263_CR93","doi-asserted-by":"publisher","first-page":"1237548","DOI":"10.3389\/fmolb.2023.1237548","volume":"10","author":"ZH Eng","year":"2023","unstructured":"Eng ZH, Abdul Aziz A, Ng KL, Mat JS. Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer. Front Mol Biosci. 2023;10:1237548.","journal-title":"Front Mol Biosci"},{"key":"2263_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110595","volume":"499","author":"C-L Liu","year":"2020","unstructured":"Liu C-L, Hsu Y-C, Lee J-J, Chen M-J, Lin C-H, Huang S-Y, et al. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Mol Cell Endocrinol. 2020;499: 110595.","journal-title":"Mol Cell Endocrinol"},{"key":"2263_CR95","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbrc.2018.03.079","volume":"498","author":"L Ma","year":"2018","unstructured":"Ma L, Cheng Q. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. Biochem Biophys Res Commun. 2018;498:912\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR96","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s00216-019-02241-y","volume":"412","author":"T Z\u00fcllig","year":"2020","unstructured":"Z\u00fcllig T, Tr\u00f6tzm\u00fcller M, K\u00f6feler HC. Lipidomics from sample preparation to data analysis: a primer. Anal Bioanal Chem. 2020;412:2191\u2013209.","journal-title":"Anal Bioanal Chem"},{"key":"2263_CR97","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34:1675\u201399.","journal-title":"Cell Metab"},{"key":"2263_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tra.12230","volume":"16","author":"JE Vance","year":"2015","unstructured":"Vance JE. Phospholipid Synthesis and Transport in Mammalian Cells. Traffic. 2015;16:1\u201318.","journal-title":"Traffic"},{"key":"2263_CR99","doi-asserted-by":"publisher","first-page":"1076548","DOI":"10.3389\/fonc.2022.1076548","volume":"12","author":"J Qin","year":"2022","unstructured":"Qin J, Yang Y, Du W, Li G, Wu Y, Luo R, et al. The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma. Front Oncol. 2022;12:1076548.","journal-title":"Front Oncol"},{"key":"2263_CR100","doi-asserted-by":"publisher","first-page":"1291445","DOI":"10.3389\/fendo.2023.1291445","volume":"14","author":"Q Ma","year":"2023","unstructured":"Ma Q, Li Y, An L, Guo L, Liu X. Assessment of causal association between differentiated thyroid cancer and disordered serum lipid profile: a Mendelian randomization study. Front Endocrinol. 2023;14:1291445.","journal-title":"Front Endocrinol"},{"key":"2263_CR101","doi-asserted-by":"crossref","unstructured":"Revilla G, Pons M de P, Baila-Rueda L, Garc\u00eda-Le\u00f3n A, Santos D, Cenarro A, et al. Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness. Sci Rep. 2019;9:10260.","DOI":"10.1038\/s41598-019-46727-2"},{"key":"2263_CR102","first-page":"595","volume":"22","author":"R Farrokhi Yekta","year":"2017","unstructured":"Farrokhi Yekta R, Rezaie Tavirani M, Arefi Oskouie A, Mohajeri-Tehrani MR, Soroush AR. The metabolomics and lipidomics window into thyroid cancer research. Biomark Biochem Indic Expo Response Susceptibility Chem. 2017;22:595\u2013603.","journal-title":"Biomark Biochem Indic Expo Response Susceptibility Chem"},{"key":"2263_CR103","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1038\/srep05959","volume":"4","author":"S Guo","year":"2014","unstructured":"Guo S, Wang Y, Zhou D, Li Z. Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging. Sci Rep. 2014;4:5959.","journal-title":"Sci Rep"},{"key":"2263_CR104","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1038\/s41598-022-12590-x","volume":"12","author":"MG Jajin","year":"2022","unstructured":"Jajin MG, Abooshahab R, Hooshmand K, Moradi A, Siadat SD, Mirzazadeh R, et al. Gas chromatography-mass spectrometry-based untargeted metabolomics reveals metabolic perturbations in medullary thyroid carcinoma. Sci Rep. 2022;12:8397.","journal-title":"Sci Rep"},{"key":"2263_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737127","volume":"11","author":"J Lu","year":"2021","unstructured":"Lu J, Zhang Y, Sun M, Ding C, Zhang L, Kong Y, et al. Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma. Front Oncol. 2021;11: 737127.","journal-title":"Front Oncol"},{"key":"2263_CR106","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s10528-022-10218-3","volume":"60","author":"C Liu","year":"2022","unstructured":"Liu C, Wang J, Li D, Ni R, Zhao M, Huang C, et al. Solute Carrier Family 27 Member 6 (SLC27A6) Possibly Promotes the Proliferation of Papillary Thyroid Cancer by Regulating c-MYC. Biochem Genet. 2022;60:2313\u201326.","journal-title":"Biochem Genet"},{"key":"2263_CR107","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1210\/jc.2004-1394","volume":"90","author":"V Porra","year":"2005","unstructured":"Porra V, Ferraro-Peyret C, Durand C, Selmi-Ruby S, Giroud H, Berger-Dutrieux N, et al. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas. J Clin Endocrinol Metab. 2005;90:3028\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR108","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","volume":"10","author":"V Ganapathy","year":"2008","unstructured":"Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, et al. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 2008;10:193\u20139.","journal-title":"AAPS J"},{"key":"2263_CR109","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","volume":"3","author":"GF Grabner","year":"2021","unstructured":"Grabner GF, Xie H, Schweiger M, Zechner R. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab. 2021;3:1445\u201365.","journal-title":"Nat Metab"},{"key":"2263_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101055","volume":"80","author":"KC Corn","year":"2020","unstructured":"Corn KC, Windham MA, Rafat M. Lipids in the tumor microenvironment: From cancer progression to treatment. Prog Lipid Res. 2020;80: 101055.","journal-title":"Prog Lipid Res"},{"key":"2263_CR111","first-page":"6114","volume":"26","author":"EG Alkurt","year":"2022","unstructured":"Alkurt EG, \u015eahin F, Tutan B, Canal K, Turhan VB. The relationship between papillary thyroid cancer and triglyceride\/glucose index, which is an indicator of insulin resistance. Eur Rev Med Pharmacol Sci. 2022;26:6114\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2263_CR112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang X-Y, et al. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100.","journal-title":"Cancer Lett"},{"key":"2263_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37: 101674.","journal-title":"Redox Biol"},{"key":"2263_CR114","doi-asserted-by":"publisher","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","volume":"161","author":"IR Schlaepfer","year":"2020","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential. Endocrinology. 2020;161:bqz046.","journal-title":"Endocrinology."},{"key":"2263_CR115","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.7150\/jca.21148","volume":"8","author":"R Wang","year":"2017","unstructured":"Wang R, Cheng Y, Su D, Gong B, He X, Zhou X, et al. Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions. J Cancer. 2017;8:3675\u201381.","journal-title":"J Cancer"},{"key":"2263_CR116","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbrc.2023.05.080","volume":"669","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang X, Yang G, Wan L, Yin F, Li H, et al. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein. Biochem Biophys Res Commun. 2023;669:95\u2013102.","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR117","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1113\/JP273185","volume":"595","author":"M Evans","year":"2017","unstructured":"Evans M, Cogan KE, Egan B. Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J Physiol. 2017;595:2857\u201371.","journal-title":"J Physiol"},{"key":"2263_CR118","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12916-021-02185-0","volume":"19","author":"H Kolb","year":"2021","unstructured":"Kolb H, Kempf K, R\u00f6hling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 2021;19:313.","journal-title":"BMC Med"},{"key":"2263_CR119","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/nu11040811","volume":"11","author":"EC Gross","year":"2019","unstructured":"Gross EC, Klement RJ, Schoenen J, D\u2019Agostino DP, Fischer D. Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention. Nutrients. 2019;11:811.","journal-title":"Nutrients"},{"key":"2263_CR120","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms24043534","volume":"24","author":"AS Manolis","year":"2023","unstructured":"Manolis AS, Manolis TA, Manolis AA. Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue. Int J Mol Sci. 2023;24:3534.","journal-title":"Int J Mol Sci"},{"key":"2263_CR121","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4155\/bio-2018-0273","volume":"11","author":"J Chen","year":"2019","unstructured":"Chen J, Hou H, Chen H, Luo Y, He Y, Zhang L, et al. Identification of \u03b2-hydroxybutyrate as a potential biomarker for female papillary thyroid cancer. Bioanalysis. 2019;11:461\u201370.","journal-title":"Bioanalysis"},{"key":"2263_CR122","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/ERC-19-0344","volume":"26","author":"J Chen","year":"2019","unstructured":"Chen J, Hu Q, Hou H, Wang S, Zhang Y, Luo Y, et al. Metabolite analysis-aided diagnosis of papillary thyroid cancer. Endocr Relat Cancer. 2019;26:829\u201341.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR123","doi-asserted-by":"crossref","unstructured":"Deja S, Dawiskiba T, Balcerzak W, Orczyk-Pawi\u0142owicz M, G\u0142\u00f3d M, Pawe\u0142ka D, et al. Follicular adenomas exhibit a unique metabolic profile. 1H NMR studies of thyroid lesions. PloS One. 2013;8:e84637.","DOI":"10.1371\/journal.pone.0084637"},{"key":"2263_CR124","first-page":"27","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun Lond Engl. 2018;38:27.","journal-title":"Cancer Commun Lond Engl"},{"key":"2263_CR125","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"2263_CR126","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/abbs\/gms112","volume":"45","author":"X Xiao","year":"2013","unstructured":"Xiao X, Song B-L. SREBP: a novel therapeutic target. Acta Biochim Biophys Sin. 2013;45:2\u201310.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2263_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109791","volume":"123","author":"C Li","year":"2020","unstructured":"Li C, Peng X, Lv J, Zou H, Liu J, Zhang K, et al. SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer. Biomed Pharmacother Biomedecine Pharmacother. 2020;123: 109791.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"2263_CR128","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12885-021-08499-9","volume":"21","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou X, Pan Y, Liu Y, Zhang Y. Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis. BMC Cancer. 2021;21:722.","journal-title":"BMC Cancer"},{"key":"2263_CR129","first-page":"755","volume":"4","author":"J Liu","year":"2011","unstructured":"Liu J, Brown RE. Immunohistochemical expressions of fatty acid synthase and phosphorylated c-Met in thyroid carcinomas of follicular origin. Int J Clin Exp Pathol. 2011;4:755\u201364.","journal-title":"Int J Clin Exp Pathol"},{"key":"2263_CR130","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1210\/jc.2008-0503","volume":"93","author":"S Uddin","year":"2008","unstructured":"Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, Myers JN, et al. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. J Clin Endocrinol Metab. 2008;93:4088\u201397.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR131","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1517\/14728222.2016.1086341","volume":"20","author":"CA von Roemeling","year":"2016","unstructured":"von Roemeling CA, Copland JA. Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma. Expert Opin Ther Targets. 2016;20:159\u201366.","journal-title":"Expert Opin Ther Targets"},{"key":"2263_CR132","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0753-3322(01)00087-7","volume":"55","author":"M Sekiguchi","year":"2001","unstructured":"Sekiguchi M, Shiroko Y, Arai T, Kishino T, Sugawara I, Kusakabe T, et al. Biological characteristics and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines. Biomed Pharmacother Biomedecine Pharmacother. 2001;55:466\u201374.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"2263_CR133","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4155\/fmc-2019-0312","volume":"12","author":"X Wu","year":"2020","unstructured":"Wu X, Huang T. Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs. Future Med Chem. 2020;12:533\u201361.","journal-title":"Future Med Chem"},{"key":"2263_CR134","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1089\/thy.2020.0311","volume":"31","author":"V Valvo","year":"2021","unstructured":"Valvo V, Iesato A, Kavanagh TR, Priolo C, Zsengeller Z, Pontecorvi A, et al. Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma. Thyroid Off J Am Thyroid Assoc. 2021;31:1335\u201358.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR135","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1530\/EJE-13-0284","volume":"169","author":"AP Vidal","year":"2013","unstructured":"Vidal AP, Andrade BM, Vaisman F, Cazarin J, Pinto LFR, Breitenbach MMD, et al. AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer. Eur J Endocrinol. 2013;169:521\u20138.","journal-title":"Eur J Endocrinol"},{"key":"2263_CR136","doi-asserted-by":"publisher","first-page":"E697","DOI":"10.1210\/jc.2014-2764","volume":"100","author":"CA von Roemeling","year":"2015","unstructured":"von Roemeling CA, Marlow LA, Pinkerton AB, Crist A, Miller J, Tun HW, et al. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab. 2015;100:E697\u2013709.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR137","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s10142-023-01215-9","volume":"23","author":"Y Cui","year":"2023","unstructured":"Cui Y, Luo J, Bai N, Yu Z. Deltex E3 ubiquitin ligase 4 promotes thyroid cancer progression through stearoyl-CoA desaturase 1. Funct Integr Genomics. 2023;23:280.","journal-title":"Funct Integr Genomics"},{"key":"2263_CR138","first-page":"288","volume":"24","author":"MH Wang","year":"2022","unstructured":"Wang MH, Ye Y, Zhang M, Zhou BR, Wang JN, Song YN, et al. Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2022;24:288\u201396.","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"2263_CR139","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/rcm.8320","volume":"33","author":"E Cadoni","year":"2019","unstructured":"Cadoni E, Vanhara P, Valletta E, Pinna E, Vascellari S, Caddeo G, et al. Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells. Rapid Commun Mass Spectrom RCM. 2019;33:97\u2013106.","journal-title":"Rapid Commun Mass Spectrom RCM"},{"key":"2263_CR140","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF03346943","volume":"9","author":"P Laccetti","year":"1986","unstructured":"Laccetti P, Meldolesi MF, Beguinot L, Mariano A, Macchia V. Alteration in the transmission of TSH-message to thyroid target in a transplantable rat thyroid tumor. J Endocrinol Invest. 1986;9:359\u201366.","journal-title":"J Endocrinol Invest"},{"key":"2263_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048873","volume":"7","author":"S Ishikawa","year":"2012","unstructured":"Ishikawa S, Tateya I, Hayasaka T, Masaki N, Takizawa Y, Ohno S, et al. Increased expression of phosphatidylcholine (16:0\/18:1) and (16:0\/18:2) in thyroid papillary cancer. PLoS ONE. 2012;7: e48873.","journal-title":"PLoS ONE"},{"key":"2263_CR142","doi-asserted-by":"publisher","first-page":"14869","DOI":"10.1038\/srep14869","volume":"5","author":"Y Tian","year":"2015","unstructured":"Tian Y, Nie X, Xu S, Li Y, Huang T, Tang H, et al. Integrative metabonomics as potential method for diagnosis of thyroid malignancy. Sci Rep. 2015;5:14869.","journal-title":"Sci Rep"},{"key":"2263_CR143","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1007\/s00216-014-7846-0","volume":"406","author":"S Guo","year":"2014","unstructured":"Guo S, Qiu L, Wang Y, Qin X, Liu H, He M, et al. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption\/ionization-Fourier transform ion cyclotron resonance mass spectrometry. Anal Bioanal Chem. 2014;406:4357\u201370.","journal-title":"Anal Bioanal Chem"},{"key":"2263_CR144","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5603\/EP.a2018.0003","volume":"69","author":"A Wojakowska","year":"2018","unstructured":"Wojakowska A, Cole LM, Chekan M, Bednarczyk K, Maksymiak M, Oczko-Wojciechowska M, et al. Discrimination of papillary thyroid cancer from non-cancerous thyroid tissue based on lipid profiling by mass spectrometry imaging. Endokrynol Pol. 2018;69:2\u20138.","journal-title":"Endokrynol Pol"},{"key":"2263_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4939-8672-9_3","volume":"1835","author":"A Aloulou","year":"2018","unstructured":"Aloulou A, Rahier R, Arhab Y, Noiriel A, Abousalham A. Phospholipases: An Overview. Methods Mol Biol Clifton NJ. 2018;1835:69\u2013105.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"2263_CR146","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/abbs\/gmab016","volume":"53","author":"L Lin","year":"2021","unstructured":"Lin L, Wen J, Lin B, Chen H, Bhandari A, Qi Y, et al. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway. Acta Biochim Biophys Sin. 2021;53:481\u201391.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2263_CR147","doi-asserted-by":"publisher","first-page":"2210339","DOI":"10.1080\/15592294.2023.2210339","volume":"18","author":"X-L Dou","year":"2023","unstructured":"Dou X-L, Xia F-D, Li X-Y. Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression. Epigenetics. 2023;18:2210339.","journal-title":"Epigenetics"},{"key":"2263_CR148","unstructured":"X L, Hs Z. Amino acid metabolism, redox balance and epigenetic regulation in cancer. FEBS J [Internet]. 2024 [cited 2024 Mar 18];291. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37129434\/"},{"key":"2263_CR149","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136.","journal-title":"Br J Cancer"},{"key":"2263_CR150","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1158\/1078-0432.CCR-23-2025","volume":"30","author":"YH Kim","year":"2024","unstructured":"Kim YH, Yoon SJ, Kim M, Kim HH, Song YS, Jung JW, et al. Integrative Multi-omics Analysis Reveals Different Metabolic Phenotypes Based on Molecular Characteristics in Thyroid Cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2024;30:883\u201394.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2263_CR151","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.clnu.2023.06.011","volume":"42","author":"H Qiu","year":"2023","unstructured":"Qiu H, Shao N, Liu J, Zhao J, Chen C, Li Q, et al. Amino acid metabolism in tumor: New shine in the fog? Clin Nutr. 2023;42:1521\u201330.","journal-title":"Clin Nutr"},{"key":"2263_CR152","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52:1496\u2013516.","journal-title":"Exp Mol Med"},{"key":"2263_CR153","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/biom12040580","volume":"12","author":"L Zhu","year":"2022","unstructured":"Zhu L, Zhu X, Wu Y. Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications. Biomolecules. 2022;12:580.","journal-title":"Biomolecules"},{"key":"2263_CR154","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41419-019-1850-4","volume":"10","author":"X Zhuang","year":"2019","unstructured":"Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y, et al. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p\/SLC1A5 axis. Cell Death Dis. 2019;10:620.","journal-title":"Cell Death Dis"},{"key":"2263_CR155","first-page":"167","volume":"34","author":"YJ Cha","year":"2019","unstructured":"Cha YJ, Jang H, Koo JS. Expression of glutamine metabolism-related proteins in H\u00fcrthle cell neoplasm of thyroid: Comparison with follicular neoplasm. Histol Histopathol. 2019;34:167\u201374.","journal-title":"Histol Histopathol"},{"key":"2263_CR156","doi-asserted-by":"crossref","unstructured":"Zhang G-Q, Xi C, Ju N-T, Shen C-T, Qiu Z-L, Song H-J, et al. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer. J Endocrinol Invest. 2024;","DOI":"10.1007\/s40618-023-02294-y"},{"key":"2263_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/metabo9020023","volume":"9","author":"L Tronci","year":"2019","unstructured":"Tronci L, Caria P, Frau DV, Liggi S, Piras C, Murgia F, et al. Crosstalk between Metabolic Alterations and Altered Redox Balance in PTC-Derived Cell Lines. Metabolites. 2019;9:23.","journal-title":"Metabolites"},{"key":"2263_CR158","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzol\u00e1 F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39:191\u20138.","journal-title":"Trends Biochem Sci"},{"key":"2263_CR159","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013;13:572\u201383.","journal-title":"Nat Rev Cancer"},{"key":"2263_CR160","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1089\/thy.2020.0105","volume":"30","author":"MJ Jeon","year":"2020","unstructured":"Jeon MJ, You M-H, Han JM, Sim S, Yoo HJ, Lee WK, et al. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer. Thyroid Off J Am Thyroid Assoc. 2020;30:1625\u201338.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR161","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41419-023-06041-2","volume":"14","author":"Y Hwang","year":"2023","unstructured":"Hwang Y, Yun HJ, Jeong JW, Kim M, Joo S, Lee H-K, et al. Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. Cell Death Dis. 2023;14:515.","journal-title":"Cell Death Dis"},{"key":"2263_CR162","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12967-016-0915-8","volume":"14","author":"WY Sun","year":"2016","unstructured":"Sun WY, Kim HM, Jung W-H, Koo JS. Expression of serine\/glycine metabolism-related proteins is different according to the thyroid cancer subtype. J Transl Med. 2016;14:168.","journal-title":"J Transl Med"},{"key":"2263_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109085","volume":"715","author":"G Gulfidan","year":"2022","unstructured":"Gulfidan G, Soylu M, Demirel D, Erdonmez HBC, Beklen H, Ozbek Sarica P, et al. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks. Arch Biochem Biophys. 2022;715: 109085.","journal-title":"Arch Biochem Biophys"},{"key":"2263_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122729","volume":"235","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wen X, Li Y, Zhang J, Li X, Qian C, et al. Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry. Talanta. 2021;235: 122729.","journal-title":"Talanta"},{"key":"2263_CR165","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/ijms22010141","volume":"22","author":"G Anderson","year":"2020","unstructured":"Anderson G. Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types-Tumour Microenvironment and Metabolism. Int J Mol Sci. 2020;22:141.","journal-title":"Int J Mol Sci"},{"key":"2263_CR166","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.3390\/ijms22179507","volume":"22","author":"A Kubicka","year":"2021","unstructured":"Kubicka A, Matczak K, \u0141abieniec-Wata\u0142a M. More Than Meets the Eye Regarding Cancer Metabolism. Int J Mol Sci. 2021;22:9507.","journal-title":"Int J Mol Sci"},{"key":"2263_CR167","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1007\/s11033-023-08421-5","volume":"50","author":"WL Tan","year":"2023","unstructured":"Tan WL, Subha ST, Mohtarrudin N, Cheah YK. An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell. Mol Biol Rep. 2023;50:5395\u2013405.","journal-title":"Mol Biol Rep"},{"key":"2263_CR168","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12672-023-00772-6","volume":"14","author":"W Sun","year":"2023","unstructured":"Sun W, Wang X, Li G, Ding C, Wang Y, Su Z, et al. Development of a thyroid cancer prognostic model based on the mitophagy-associated differentially expressed genes. Discov Oncol. 2023;14:173.","journal-title":"Discov Oncol"},{"key":"2263_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.932754","volume":"13","author":"K Hamada","year":"2022","unstructured":"Hamada K, Kurashige T, Shimamura M, Arakawa H, Nakamura Y, Nagayama Y. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAFV600E-positive thyroid cancer. Front Endocrinol. 2022;13: 932754.","journal-title":"Front Endocrinol"},{"key":"2263_CR170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122308","volume":"10","author":"A Ferreira-da-Silva","year":"2015","unstructured":"Ferreira-da-Silva A, Valacca C, Rios E, P\u00f3pulo H, Soares P, Sobrinho-Sim\u00f5es M, et al. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PLoS ONE. 2015;10: e0122308.","journal-title":"PLoS ONE"},{"key":"2263_CR171","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/cells7050040","volume":"7","author":"FA Zimmermann","year":"2018","unstructured":"Zimmermann FA, Neureiter D, Sperl W, Mayr JA, Kofler B. Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma. Cells. 2018;7:40.","journal-title":"Cells"},{"key":"2263_CR172","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/cas.14501","volume":"111","author":"Z Mussazhanova","year":"2020","unstructured":"Mussazhanova Z, Shimamura M, Kurashige T, Ito M, Nakashima M, Nagayama Y. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Cancer Sci. 2020;111:2814\u201323.","journal-title":"Cancer Sci"},{"key":"2263_CR173","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/ijms23010460","volume":"23","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Nikiforov NG, Zhuravlev AD, Orekhov NA, Mikhaleva LM, Orekhov AN. The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment. Int J Mol Sci. 2021;23:460.","journal-title":"Int J Mol Sci"},{"key":"2263_CR174","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41419-021-03505-1","volume":"12","author":"X Bao","year":"2021","unstructured":"Bao X, Zhang J, Huang G, Yan J, Xu C, Dou Z, et al. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis. 2021;12:215.","journal-title":"Cell Death Dis"},{"key":"2263_CR175","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci. 2021;22:5703.","journal-title":"Int J Mol Sci"},{"key":"2263_CR176","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12957-022-02815-8","volume":"20","author":"L Zhang","year":"2022","unstructured":"Zhang L, Shi B, Hu M, Qian L. HIF-1\u03b1 and Caspase-3 expression in aggressive papillary thyroid carcinoma. World J Surg Oncol. 2022;20:353.","journal-title":"World J Surg Oncol"},{"key":"2263_CR177","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7150\/ijbs.75459","volume":"19","author":"H Song","year":"2023","unstructured":"Song H, Qiu Z, Wang Y, Xi C, Zhang G, Sun Z, et al. HIF-1\u03b1\/YAP Signaling Rewrites Glucose\/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression. Int J Biol Sci. 2023;19:225\u201341.","journal-title":"Int J Biol Sci"},{"key":"2263_CR178","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/cancers13020185","volume":"13","author":"P Pratheeshkumar","year":"2021","unstructured":"Pratheeshkumar P, Siraj AK, Divya SP, Parvathareddy SK, Siraj S, Diaz R, et al. Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer. Cancers. 2021;13:185.","journal-title":"Cancers"},{"key":"2263_CR179","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mc.23648","volume":"63","author":"D Wang","year":"2024","unstructured":"Wang D, Liu X, Li M, Ning J. HIF-1\u03b1 regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2\/NF-\u03baB signaling pathway. Mol Carcinog. 2024;63:238\u201352.","journal-title":"Mol Carcinog"},{"key":"2263_CR180","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/0929867321666131201142434","volume":"21","author":"S Rajoria","year":"2014","unstructured":"Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, et al. Interlinking of hypoxia and estrogen in thyroid cancer progression. Curr Med Chem. 2014;21:1351\u201360.","journal-title":"Curr Med Chem"},{"key":"2263_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22168","volume":"85","author":"Z Liang","year":"2024","unstructured":"Liang Z, He H, Zhang B, Kai Z, Zong L. Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathway. Drug Dev Res. 2024;85: e22168.","journal-title":"Drug Dev Res"},{"key":"2263_CR182","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41416-023-02282-2","volume":"129","author":"M Aprile","year":"2023","unstructured":"Aprile M, Cataldi S, Perfetto C, Federico A, Ciccodicola A, Costa V. Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1\u03b1-mediated glycolytic phenotype. Br J Cancer. 2023;129:249.","journal-title":"Br J Cancer"},{"key":"2263_CR183","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S. The functional roles of TCA cycle metabolites in cancer. Oncogene. 2021;40:3351\u201363.","journal-title":"Oncogene"},{"key":"2263_CR184","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2010.02.095","volume":"393","author":"AK Murugan","year":"2010","unstructured":"Murugan AK, Bojdani E, Xing M. Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer. Biochem Biophys Res Commun. 2010;393:555\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR185","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/ERC-14-0537","volume":"22","author":"Y Ni","year":"2015","unstructured":"Ni Y, Seballos S, Ganapathi S, Gurin D, Fletcher B, Ngeow J, et al. Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer. Endocr Relat Cancer. 2015;22:121\u201330.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR186","doi-asserted-by":"publisher","first-page":"E2063","DOI":"10.1210\/jc.2011-1616","volume":"96","author":"J Ngeow","year":"2011","unstructured":"Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011;96:E2063\u20132071.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR187","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/hmg\/ddx037","volume":"26","author":"W Yu","year":"2017","unstructured":"Yu W, Ni Y, Saji M, Ringel MD, Jaini R, Eng C. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells. Hum Mol Genet. 2017;26:1365\u201375.","journal-title":"Hum Mol Genet"},{"key":"2263_CR188","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/clinem\/dgac386","volume":"107","author":"AS Alzahrani","year":"2022","unstructured":"Alzahrani AS, Alswailem M, Alghamdi B, Al-Hindi H. Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer. J Clin Endocrinol Metab. 2022;107:2539\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR189","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2023.04.008","volume":"9","author":"DD Shi","year":"2023","unstructured":"Shi DD, Savani MR, Abdullah KG, McBrayer SK. Emerging roles of nucleotide metabolism in cancer. Trends Cancer. 2023;9:624\u201335.","journal-title":"Trends Cancer"},{"key":"2263_CR190","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","volume":"8","author":"M Bonora","year":"2012","unstructured":"Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, et al. ATP synthesis and storage. Purinergic Signal. 2012;8:343\u201357.","journal-title":"Purinergic Signal"},{"key":"2263_CR191","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023;23:275\u201394.","journal-title":"Nat Rev Cancer"},{"key":"2263_CR192","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/thy.1993.3.105","volume":"3","author":"W Luo","year":"1993","unstructured":"Luo W, Matsuo K, Nagayama Y, Urano T, Furukawa K, Takeshita A, et al. Immunohistochemical analysis of expression of nm23-H1\/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Thyroid Off J Am Thyroid Assoc. 1993;3:105\u20139.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR193","first-page":"26","volume":"145","author":"P Bertheau","year":"1994","unstructured":"Bertheau P, De La Rosa A, Steeg PS, Merino MJ. NM23 protein in neoplastic and nonneoplastic thyroid tissues. Am J Pathol. 1994;145:26\u201332.","journal-title":"Am J Pathol"},{"key":"2263_CR194","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.prp.2008.08.007","volume":"205","author":"HM Tabriz","year":"2009","unstructured":"Tabriz HM, Adabi K, Lashkari A, Heshmat R, Haghpanah V, Larijani B, et al. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Pathol Res Pract. 2009;205:83\u20137.","journal-title":"Pathol Res Pract"},{"key":"2263_CR195","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/ijc.33889","volume":"150","author":"MA Laaksonen","year":"2022","unstructured":"Laaksonen MA, MacInnis RJ, Canfell K, Shaw JE, Magliano DJ, Banks E, et al. Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study. Int J Cancer. 2022;150:1281\u201390.","journal-title":"Int J Cancer"},{"key":"2263_CR196","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jnci\/djz202","volume":"112","author":"CM Kitahara","year":"2020","unstructured":"Kitahara CM, Pfeiffer RM, Sosa JA, Shiels MS. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995\u20132015). J Natl Cancer Inst. 2020;112:810\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"2263_CR197","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/thy.2013.0232","volume":"24","author":"T Pappa","year":"2014","unstructured":"Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update. Thyroid Off J Am Thyroid Assoc. 2014;24:190\u20139.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR198","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13105-021-00789-x","volume":"77","author":"E Nigro","year":"2021","unstructured":"Nigro E, Orlandella FM, Polito R, Mariniello RM, Monaco ML, Mallardo M, et al. Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines. J Physiol Biochem. 2021;77:237\u201348.","journal-title":"J Physiol Biochem"},{"key":"2263_CR199","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41419-024-07084-9","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Zhang J, Dionigi G, Liang N, Guan H, Sun H. Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2-ULK axis. Cell Death Dis. 2024;15:708.","journal-title":"Cell Death Dis"},{"key":"2263_CR200","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41467-021-23643-6","volume":"12","author":"G Pacini","year":"2021","unstructured":"Pacini G, Dunkel I, Mages N, Mutzel V, Timmermann B, Marsico A, et al. Integrated analysis of Xist upregulation and X-chromosome inactivation with single-cell and single-allele resolution. Nat Commun. 2021;12:3638.","journal-title":"Nat Commun"},{"key":"2263_CR201","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13046-018-0950-9","volume":"37","author":"H Liu","year":"2018","unstructured":"Liu H, Deng H, Zhao Y, Li C, Liang Y. LncRNA XIST\/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res CR. 2018;37:279.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR202","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10528-020-09985-8","volume":"59","author":"Y-L Du","year":"2021","unstructured":"Du Y-L, Liang Y, Cao Y, Liu L, Li J, Shi G-Q. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p\/CLDN1 Axis. Biochem Genet. 2021;59:437\u201352.","journal-title":"Biochem Genet"},{"key":"2263_CR203","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284242","volume":"18","author":"F Yang","year":"2023","unstructured":"Yang F, Zhang J, Zhao Z, Liu Y, Zhao Z, Fu K, et al. Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST\/miR-93\/HIF-1a pathway. PLoS ONE. 2023;18: e0284242.","journal-title":"PLoS ONE"},{"key":"2263_CR204","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2741\/s166","volume":"3","author":"JC Prior","year":"2011","unstructured":"Prior JC, Hitchcock CL. The endocrinology of perimenopause: need for a paradigm shift. Front Biosci Sch Ed. 2011;3:474\u201386.","journal-title":"Front Biosci Sch Ed"},{"key":"2263_CR205","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12672-022-00599-7","volume":"14","author":"L-R Li","year":"2023","unstructured":"Li L-R, Song J-L, Liu H-Q, Chen C. Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism. Discov Oncol. 2023;14:23.","journal-title":"Discov Oncol"},{"key":"2263_CR206","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"J-A Kim","year":"2008","unstructured":"Kim J-A, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401\u201314.","journal-title":"Circ Res"},{"key":"2263_CR207","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms24054642","volume":"24","author":"C Delrue","year":"2023","unstructured":"Delrue C, Speeckaert MM. Vitamin D and Vitamin D-Binding Protein in Health and Disease. Int J Mol Sci. 2023;24:4642.","journal-title":"Int J Mol Sci"},{"key":"2263_CR208","first-page":"5","volume":"57","author":"J Zhao","year":"2019","unstructured":"Zhao J, Wang H, Zhang Z, Zhou X, Yao J, Zhang R, et al. Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies. Nutr Burbank Los Angel Cty Calif. 2019;57:5\u201311.","journal-title":"Nutr Burbank Los Angel Cty Calif"},{"key":"2263_CR209","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/genes10080572","volume":"10","author":"IS Carvalho","year":"2019","unstructured":"Carvalho IS, Gon\u00e7alves CI, Almeida JT, Azevedo T, Martins T, Rodrigues FJ, et al. Association of Vitamin D Pathway Genetic Variation and Thyroid Cancer. Genes. 2019;10:572.","journal-title":"Genes"},{"key":"2263_CR210","first-page":"1","volume":"50","author":"S-M Jeon","year":"2018","unstructured":"Jeon S-M, Shin E-A. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50:1\u201314.","journal-title":"Exp Mol Med"},{"key":"2263_CR211","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/nu12051444","volume":"12","author":"C Mele","year":"2020","unstructured":"Mele C, Caputo M, Bisceglia A, Sam\u00e0 MT, Zavattaro M, Aimaretti G, et al. Immunomodulatory Effects of Vitamin D in Thyroid Diseases. Nutrients. 2020;12:1444.","journal-title":"Nutrients"},{"key":"2263_CR212","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/odi.12446","volume":"22","author":"SJ Padayatty","year":"2016","unstructured":"Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22:463\u201393.","journal-title":"Oral Dis"},{"key":"2263_CR213","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13046-021-02134-y","volume":"40","author":"F B\u00f6ttger","year":"2021","unstructured":"B\u00f6ttger F, Vall\u00e9s-Mart\u00ed A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res CR. 2021;40:343.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR214","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.7150\/thno.35219","volume":"9","author":"X Su","year":"2019","unstructured":"Su X, Shen Z, Yang Q, Sui F, Pu J, Ma J, et al. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms. Theranostics. 2019;9:4461\u201373.","journal-title":"Theranostics"},{"key":"2263_CR215","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/antiox10050809","volume":"10","author":"L Tronci","year":"2021","unstructured":"Tronci L, Serreli G, Piras C, Frau DV, Dettori T, Deiana M, et al. Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines. Antioxid Basel Switz. 2021;10:809.","journal-title":"Antioxid Basel Switz"},{"key":"2263_CR216","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-021-01831-y","volume":"40","author":"X Su","year":"2021","unstructured":"Su X, Li P, Han B, Jia H, Liang Q, Wang H, et al. Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK\/ERK signal by PLX4032. J Exp Clin Cancer Res CR. 2021;40:34.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR217","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2021.02.126","volume":"551","author":"X Wang","year":"2021","unstructured":"Wang X, Xu S, Zhang L, Cheng X, Yu H, Bao J, et al. Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation. Biochem Biophys Res Commun. 2021;551:46\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR218","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-017-0388-y","volume":"24","author":"P J\u00f3\u017awiak","year":"2017","unstructured":"J\u00f3\u017awiak P, Ciesielski P, Zaczek A, Lipi\u0144ska A, Pomorski L, Wieczorek M, et al. Expression of hypoxia inducible factor 1\u03b1 and 2\u03b1 and its association with vitamin C level in thyroid lesions. J Biomed Sci. 2017;24:83.","journal-title":"J Biomed Sci"},{"key":"2263_CR219","doi-asserted-by":"crossref","unstructured":"Capriello S, Stramazzo I, Bagaglini MF, Brusca N, Virili C, Centanni M. The relationship between thyroid disorders and vitamin A.: A narrative minireview. Front Endocrinol. 2022;13:968215.","DOI":"10.3389\/fendo.2022.968215"},{"key":"2263_CR220","doi-asserted-by":"publisher","first-page":"T141","DOI":"10.1530\/ERC-21-0217","volume":"28","author":"G Riesco-Eizaguirre","year":"2021","unstructured":"Riesco-Eizaguirre G, Santisteban P, De la Vieja A. The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues. Endocr Relat Cancer. 2021;28:T141\u201365.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR221","doi-asserted-by":"crossref","unstructured":"Liu C-L, Hsu Y-C, Kuo C-Y, Jhuang J-Y, Li Y-S, Cheng S-P. CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin\/FAK\/AKT Pathway. Endocrinology. 2022;163:bqac171.","DOI":"10.1210\/endocr\/bqac171"},{"key":"2263_CR222","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/MNM.0000000000000727","volume":"38","author":"A Upadhyaya","year":"2017","unstructured":"Upadhyaya A, Zhou P, Meng Z, Wang P, Zhang G, Jia Q, et al. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial. Nucl Med Commun. 2017;38:891\u2013903.","journal-title":"Nucl Med Commun"},{"key":"2263_CR223","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/MNM.0000000000001605","volume":"43","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Tong H, Li X, Zhang X, Fang J, Yue R, et al. Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I. Nucl Med Commun. 2022;43:995\u20131003.","journal-title":"Nucl Med Commun"},{"key":"2263_CR224","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MNM.0b013e328362b1f2","volume":"34","author":"B Fallahi","year":"2013","unstructured":"Fallahi B, Beiki D, Abedi SM, Saghari M, Fard-Esfahani A, Akhzari F, et al. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? Nucl Med Commun. 2013;34:777\u201386.","journal-title":"Nucl Med Commun"},{"key":"2263_CR225","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/mc.23160","volume":"59","author":"CS Yang","year":"2020","unstructured":"Yang CS, Luo P, Zeng Z, Wang H, Malafa M, Suh N. Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols. Mol Carcinog. 2020;59:365\u201389.","journal-title":"Mol Carcinog"},{"key":"2263_CR226","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1080\/10408398.2018.1474169","volume":"59","author":"A Abraham","year":"2019","unstructured":"Abraham A, Kattoor AJ, Saldeen T, Mehta JL. Vitamin E and its anticancer effects. Crit Rev Food Sci Nutr. 2019;59:2831\u20138.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2263_CR227","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1158\/2159-8290.CD-21-0900","volume":"12","author":"X Yuan","year":"2022","unstructured":"Yuan X, Duan Y, Xiao Y, Sun K, Qi Y, Zhang Y, et al. Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1. Cancer Discov. 2022;12:1742\u201359.","journal-title":"Cancer Discov"},{"key":"2263_CR228","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","volume":"17","author":"MD Jelic","year":"2021","unstructured":"Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021;17:22\u20138.","journal-title":"J Cancer Res Ther"},{"key":"2263_CR229","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4161\/oxim.3.1.10095","volume":"3","author":"A Acharya","year":"2010","unstructured":"Acharya A, Das I, Chandhok D, Saha T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev. 2010;3:23\u201334.","journal-title":"Oxid Med Cell Longev"},{"key":"2263_CR230","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"2263_CR231","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","volume":"387","author":"S Prasad","year":"2017","unstructured":"Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95\u2013105.","journal-title":"Cancer Lett"},{"key":"2263_CR232","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13046-019-1328-3","volume":"38","author":"W Chai","year":"2019","unstructured":"Chai W, Ye F, Zeng L, Li Y, Yang L. HMGB1-mediated autophagy regulates sodium\/iodide symporter protein degradation in thyroid cancer cells. J Exp Clin Cancer Res CR. 2019;38:325.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2263_CR233","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/ERC-17-0288","volume":"25","author":"WE Corver","year":"2018","unstructured":"Corver WE, Demmers J, Oosting J, Sahraeian S, Boot A, Ruano D, et al. ROS-induced near-homozygous genomes in thyroid cancer. Endocr Relat Cancer. 2018;25:83\u201397.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR234","first-page":"9982449","volume":"2022","author":"S Chen","year":"2022","unstructured":"Chen S, Bao X, Chen H, Jia M, Li W, Zhang L, et al. Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1\/2 Activation. Oxid Med Cell Longev. 2022;2022:9982449.","journal-title":"Oxid Med Cell Longev"},{"key":"2263_CR235","first-page":"8038857","volume":"2022","author":"J Zhu","year":"2022","unstructured":"Zhu J, Zheng X, Lu D, Zheng Y, Liu J. Clinical Relevance and Tumor Growth Suppression of Mitochondrial ROS Regulators along NADH: Ubiquinone Oxidoreductase Subunit B3 in Thyroid Cancer. Oxid Med Cell Longev. 2022;2022:8038857.","journal-title":"Oxid Med Cell Longev"},{"key":"2263_CR236","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"2263_CR237","doi-asserted-by":"publisher","first-page":"230","DOI":"10.18632\/aging.204473","volume":"15","author":"H Chen","year":"2023","unstructured":"Chen H, Peng F, Xu J, Wang G, Zhao Y. Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes. Aging. 2023;15:230\u201345.","journal-title":"Aging"},{"key":"2263_CR238","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00268-022-06738-z","volume":"47","author":"KR Sekhar","year":"2023","unstructured":"Sekhar KR, Cyr S, Baregamian N. Ferroptosis Inducers in Thyroid Cancer. World J Surg. 2023;47:371\u201381.","journal-title":"World J Surg"},{"key":"2263_CR239","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00259-020-05018-z","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Verburg FA, Hoffmann M, Iakovou I, Mihailovic J, Vrachimis A, et al. Higher thyroid hormone levels and cancer. Eur J Nucl Med Mol Imaging. 2021;48:808\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2263_CR240","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004049","volume":"10","author":"Z Wu","year":"2022","unstructured":"Wu Z, Xi Z, Xiao Y, Zhao X, Li J, Feng N, et al. TSH-TSHR axis promotes tumor immune evasion. J Immunother Cancer. 2022;10: e004049.","journal-title":"J Immunother Cancer"},{"key":"2263_CR241","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13:877\u2013919.","journal-title":"Protein Cell"},{"key":"2263_CR242","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12935-021-02405-w","volume":"21","author":"G Huang","year":"2021","unstructured":"Huang G, Chen J, Zhou J, Xiao S, Zeng W, Xia J, et al. Epigenetic modification and BRAF gene mutation in thyroid carcinoma. Cancer Cell Int. 2021;21:687.","journal-title":"Cancer Cell Int"},{"key":"2263_CR243","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.18632\/aging.101143","volume":"8","author":"K Daniell","year":"2016","unstructured":"Daniell K, Nucera C. Effect of the micronutrient iodine in thyroid carcinoma angiogenesis. Aging. 2016;8:3180\u20134.","journal-title":"Aging"},{"key":"2263_CR244","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1038\/s41598-022-23906-2","volume":"12","author":"KR Sekhar","year":"2022","unstructured":"Sekhar KR, Hanna DN, Cyr S, Baechle JJ, Kuravi S, Balusu R, et al. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. Sci Rep. 2022;12:19396.","journal-title":"Sci Rep"},{"key":"2263_CR245","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: A Review. JAMA. 2024;331:425\u201335.","journal-title":"JAMA"},{"key":"2263_CR246","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-8587(22)00101-2","volume":"10","author":"EK Alexander","year":"2022","unstructured":"Alexander EK, Cibas ES. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 2022;10:533\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2263_CR247","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11307-006-0072-1","volume":"9","author":"A Iagaru","year":"2007","unstructured":"Iagaru A, Masamed R, Singer PA, Conti PS. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2- [F-18]fluoro-D-glucose-PET and PET\/CT. Mol Imaging Biol. 2007;9:72\u20137.","journal-title":"Mol Imaging Biol"},{"key":"2263_CR248","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11604-022-01376-w","volume":"41","author":"C Okuyama","year":"2023","unstructured":"Okuyama C, Higashi T, Ishizu K, Saga T. FDG-PET findings associated with various medical procedures and treatments. Jpn J Radiol. 2023;41:459\u201376.","journal-title":"Jpn J Radiol"},{"key":"2263_CR249","doi-asserted-by":"crossref","unstructured":"Shi Y, Feng Y, Xu L, Li W, Guan L, Zuo R, et al. The value of Gallium-68 prostate-specific membrane antigen ( [68Ga]Ga-PSMA-11) PET\/CT and 2- [18F]fluoro-2-deoxy-D-glucose (2- [18F]FDG) PET\/CT in the detection of thyroid cancer lesions: a prospective head-to-head comparison. Br J Radiol. 2023;20230291.","DOI":"10.1259\/bjr.20230291"},{"key":"2263_CR250","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s00259-019-04543-w","volume":"47","author":"X Xu","year":"2020","unstructured":"Xu X, Zhu H, Liu F, Zhang Y, Yang J, Zhang L, et al. Dynamic PET\/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients. Eur J Nucl Med Mol Imaging. 2020;47:2280\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2263_CR251","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.7150\/thno.24997","volume":"8","author":"H Jiang","year":"2018","unstructured":"Jiang H, DeGrado TR. [18F]Tetrafluoroborate ( [18F]TFB) and its analogs for PET imaging of the sodium\/iodide symporter. Theranostics. 2018;8:3918\u201331.","journal-title":"Theranostics"},{"key":"2263_CR252","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1007\/s00216-023-04954-7","volume":"415","author":"W Ma","year":"2023","unstructured":"Ma W, Chen H, Hou H, Hu Q, Bai Y. TiO2@COF-based solid-phase microextraction combined with UHPLC-MS\/MS for the rapid determination of potential biomarkers of phosphatidylcholines and lysophosphatidylcholines in head and neck cancers. Anal Bioanal Chem. 2023;415:6771\u201383.","journal-title":"Anal Bioanal Chem"},{"key":"2263_CR253","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s13361-016-1570-2","volume":"28","author":"J Zhang","year":"2017","unstructured":"Zhang J, Feider CL, Nagi C, Yu W, Carter SA, Suliburk J, et al. Detection of Metastatic Breast and Thyroid Cancer in Lymph Nodes by Desorption Electrospray Ionization Mass Spectrometry Imaging. J Am Soc Mass Spectrom. 2017;28:1166\u201374.","journal-title":"J Am Soc Mass Spectrom"},{"key":"2263_CR254","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1021\/acs.jpcb.9b01159","volume":"123","author":"JN Taylor","year":"2019","unstructured":"Taylor JN, Mochizuki K, Hashimoto K, Kumamoto Y, Harada Y, Fujita K, et al. High-Resolution Raman Microscopic Detection of Follicular Thyroid Cancer Cells with Unsupervised Machine Learning. J Phys Chem B. 2019;123:4358\u201372.","journal-title":"J Phys Chem B"},{"key":"2263_CR255","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cyt.12636","volume":"30","author":"D O\u2019Dea","year":"2019","unstructured":"O\u2019Dea D, Bongiovanni M, Sykiotis GP, Ziros PG, Meade AD, Lyng FM, et al. Raman spectroscopy for the preoperative diagnosis of thyroid cancer and its subtypes: An in vitro proof-of-concept study. Cytopathol Off J Br Soc Clin Cytol. 2019;30:51\u201360.","journal-title":"Cytopathol Off J Br Soc Clin Cytol"},{"key":"2263_CR256","doi-asserted-by":"publisher","first-page":"1199291","DOI":"10.3389\/fendo.2023.1199291","volume":"14","author":"A Hellmann","year":"2023","unstructured":"Hellmann A, Turyn J, Zwara A, Korczynska J, Taciak A, Mika A. Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto\u2019s thyroiditis. Front Endocrinol. 2023;14:1199291.","journal-title":"Front Endocrinol"},{"key":"2263_CR257","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer. 2021;149:984\u201392.","journal-title":"Int J Cancer"},{"key":"2263_CR258","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M. New Therapies for Advanced Thyroid Cancer. Front Endocrinol. 2020;11:82.","journal-title":"Front Endocrinol"},{"key":"2263_CR259","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"Cabanillas ME, Ryder M, Jimenez C. Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond. Endocr Rev. 2019;40:1573\u2013604.","journal-title":"Endocr Rev"},{"key":"2263_CR260","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2022.04.004","volume":"246","author":"L Chen","year":"2022","unstructured":"Chen L, Zhuo D, Yuan H. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K\/AKT\/mTOR signaling pathway. Immunol Lett. 2022;246:10\u20137.","journal-title":"Immunol Lett"},{"key":"2263_CR261","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13258-020-01023-6","volume":"43","author":"Y Li","year":"2021","unstructured":"Li Y, Qin J, He Z, Cui G, Zhang K, Wu B. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p. Genes Genomics. 2021;43:141\u201350.","journal-title":"Genes Genomics"},{"key":"2263_CR262","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1089\/hum.2018.160","volume":"30","author":"Y Miao","year":"2019","unstructured":"Miao Y, Zhang L-F, Zhang M, Guo R, Liu M-F, Li B. Therapeutic Delivery of miR-143 Targeting Tumor Metabolism in Poorly Differentiated Thyroid Cancer Xenografts and Efficacy Evaluation Using 18F-FDG MicroPET-CT. Hum Gene Ther. 2019;30:882\u201392.","journal-title":"Hum Gene Ther"},{"key":"2263_CR263","doi-asserted-by":"publisher","first-page":"E2361","DOI":"10.1073\/pnas.1201232109","volume":"109","author":"JP Couto","year":"2012","unstructured":"Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Sim\u00f5es M, et al. STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A. 2012;109:E2361\u20132370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2263_CR264","doi-asserted-by":"publisher","first-page":"19019","DOI":"10.1002\/jcp.28541","volume":"234","author":"K Wang","year":"2019","unstructured":"Wang K, Chai L, Qiu Z, Zhang Y, Gao H, Zhang X. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells. J Cell Physiol. 2019;234:19019\u201327.","journal-title":"J Cell Physiol"},{"key":"2263_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115659","volume":"168","author":"J Ouyang","year":"2023","unstructured":"Ouyang J, Feng Y, Zhang Y, Liu Y, Li S, Wang J, et al. Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication. Biomed Pharmacother Biomedecine Pharmacother. 2023;168: 115659.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"2263_CR266","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/biom12040574","volume":"12","author":"M Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Garc\u00eda-S\u00e1enz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications. Biomolecules. 2022;12:574.","journal-title":"Biomolecules"},{"key":"2263_CR267","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12020-021-02977-7","volume":"76","author":"Y Yu","year":"2022","unstructured":"Yu Y, Feng C, Kuang J, Guo L, Guan H. Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion. Endocrine. 2022;76:116\u201331.","journal-title":"Endocrine"},{"key":"2263_CR268","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12935-022-02496-z","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang L, Mao L, Zhang L, Zhu Y, Xu Y, et al. SGLT2 inhibition restrains thyroid cancer growth via G1\/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways. Cancer Cell Int. 2022;22:74.","journal-title":"Cancer Cell Int"},{"key":"2263_CR269","doi-asserted-by":"publisher","first-page":"1323083","DOI":"10.3389\/fphar.2024.1323083","volume":"15","author":"A Buczy\u0144ska","year":"2024","unstructured":"Buczy\u0144ska A, Ko\u015bciuszko M, Kr\u0119towski AJ, Pop\u0142awska-Kita A. Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review. Front Pharmacol. 2024;15:1323083.","journal-title":"Front Pharmacol"},{"key":"2263_CR270","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-20-0135","volume":"27","author":"M Wagner","year":"2020","unstructured":"Wagner M, Wuest M, Lopez-Campistrous A, Glubrecht D, Dufour J, Jans H-S, et al. Tyrosine kinase inhibitor therapy and metabolic remodelling in papillary thyroid cancer. Endocr Relat Cancer. 2020;27:495\u2013507.","journal-title":"Endocr Relat Cancer"},{"key":"2263_CR271","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.surg.2021.05.055","volume":"171","author":"B Zhao","year":"2022","unstructured":"Zhao B, Aggarwal A, Marshall JA, Barletta JA, Kijewski MF, Lorch JH, et al. Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer. Surgery. 2022;171:227\u201334.","journal-title":"Surgery"},{"key":"2263_CR272","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1210\/jc.2014-3023","volume":"100","author":"M Ruan","year":"2015","unstructured":"Ruan M, Liu M, Dong Q, Chen L. Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer. J Clin Endocrinol Metab. 2015;100:1771\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR273","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22142","volume":"85","author":"Y Gao","year":"2024","unstructured":"Gao Y, Tao W, Wang S, Duan R, Zhang Z. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling. Drug Dev Res. 2024;85: e22142.","journal-title":"Drug Dev Res"},{"key":"2263_CR274","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.1111\/jcmm.16806","volume":"25","author":"B Jiang","year":"2021","unstructured":"Jiang B, Chen Y, Xia F, Li X. PTCSC3-mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation. J Cell Mol Med. 2021;25:8454\u201363.","journal-title":"J Cell Mol Med"},{"key":"2263_CR275","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jconrel.2024.03.057","volume":"369","author":"Z Pan","year":"2024","unstructured":"Pan Z, Lu X, Hu X, Yu R, Che Y, Wang J, et al. Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters. J Control Release Off J Control Release Soc. 2024;369:517\u201330.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"2263_CR276","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/XCS.0000000000000226","volume":"234","author":"B Zhao","year":"2022","unstructured":"Zhao B, Aggarwal A, Im S-Y, Viswanathan K, Landa I, Nehs MA. Effect of Lactate Export Inhibition on Anaplastic Thyroid Cancer Growth and Metabolism. J Am Coll Surg. 2022;234:1044\u201350.","journal-title":"J Am Coll Surg"},{"key":"2263_CR277","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.2147\/OTT.S230597","volume":"12","author":"L Huang","year":"2019","unstructured":"Huang L, Cai Y, Luo Y, Xiong D, Hou Z, Lv J, et al. JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1\/NF-\u03baB Pathways. OncoTargets Ther. 2019;12:10501\u201314.","journal-title":"OncoTargets Ther"},{"key":"2263_CR278","doi-asserted-by":"crossref","unstructured":"Davidson CD, Tomczak JA, Amiel E, Carr FE. Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice. Endocrinology. 2022;163:bqac169.","DOI":"10.1210\/endocr\/bqac169"},{"key":"2263_CR279","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ijms22031077","volume":"22","author":"YJ Choi","year":"2021","unstructured":"Choi YJ, Lee J-E, Ji HD, Lee B-R, Lee SB, Kim KS, et al. Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer. Int J Mol Sci. 2021;22:1077.","journal-title":"Int J Mol Sci"},{"key":"2263_CR280","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130959","volume":"10","author":"S-Y Wang","year":"2015","unstructured":"Wang S-Y, Wei Y-H, Shieh D-B, Lin L-L, Cheng S-P, Wang P-W, et al. 2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells. PLoS ONE. 2015;10: e0130959.","journal-title":"PLoS ONE"},{"key":"2263_CR281","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.biocel.2008.10.021","volume":"41","author":"G Rath","year":"2009","unstructured":"Rath G, Schneider C, Langlois B, Sartelet H, Morjani H, Btaouri HEL, et al. De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma. Int J Biochem Cell Biol. 2009;41:1165\u201372.","journal-title":"Int J Biochem Cell Biol"},{"key":"2263_CR282","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00018-024-05146-x","volume":"81","author":"Q Li","year":"2024","unstructured":"Li Q, Wang Y, Meng X, Wang W, Duan F, Chen S, et al. METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A\/YTHDC2\/SCD1-regulated lipid metabolism. Cell Mol Life Sci CMLS. 2024;81:81.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2263_CR283","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.18632\/aging.203172","volume":"13","author":"W Chen","year":"2021","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D, et al. Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging. 2021;13:16500\u201312.","journal-title":"Aging"},{"key":"2263_CR284","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/OTT.S189536","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen Z, Lin J, Feng S, Chen X, Huang H, Wang C, et al. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism. OncoTargets Ther. 2019;12:2397\u2013408.","journal-title":"OncoTargets Ther"},{"key":"2263_CR285","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-023-05981-z","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Liu Y, Liu J, Qiang W, Ma J, Xie J, et al. STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. Cell Death Dis. 2023;14:454.","journal-title":"Cell Death Dis"},{"key":"2263_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100996","volume":"52","author":"Q Xu","year":"2024","unstructured":"Xu Q, Wang J, Mao Y, Xuan Z, Yang K, Tang X, et al. Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms. Neoplasia N Y N. 2024;52: 100996.","journal-title":"Neoplasia N Y N"},{"key":"2263_CR287","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216304","volume":"568","author":"AJ Sugarman","year":"2023","unstructured":"Sugarman AJ, Huynh LD, Shabro A, Di Cristofano A. Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability. Cancer Lett. 2023;568: 216304.","journal-title":"Cancer Lett"},{"key":"2263_CR288","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ptr.7361","volume":"36","author":"L Wu","year":"2022","unstructured":"Wu L, Xu S, Cheng X, Zhang L, Wang Y, Wu J, et al. Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation. Phytother Res PTR. 2022;36:938\u201350.","journal-title":"Phytother Res PTR"},{"key":"2263_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109733","volume":"75","author":"S Xu","year":"2020","unstructured":"Xu S, Cheng X, Wu L, Zheng J, Wang X, Wu J, et al. Capsaicin induces mitochondrial dysfunction and apoptosis in anaplastic thyroid carcinoma cells via TRPV1-mediated mitochondrial calcium overload. Cell Signal. 2020;75: 109733.","journal-title":"Cell Signal"},{"key":"2263_CR290","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/jmcb\/mjab072","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Cheng X, Wu J, Wang Y, Wang X, Wu L, et al. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH-TSHR pathway in anaplastic thyroid carcinoma cells. J Mol Cell Biol. 2022;13:791\u2013807.","journal-title":"J Mol Cell Biol"},{"key":"2263_CR291","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.111534","volume":"197","author":"T Yu","year":"2019","unstructured":"Yu T, Tong L, Ao Y, Zhang G, Liu Y, Zhang H. Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy. J Photochem Photobiol B. 2019;197: 111534.","journal-title":"J Photochem Photobiol B"},{"key":"2263_CR292","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.3390\/ijms24098048","volume":"24","author":"T-H Lin","year":"2023","unstructured":"Lin T-H, Kuo C-H, Zhang Y-S, Chen P-T, Chen S-H, Li Y-Z, et al. Piperlongumine Induces Cellular Apoptosis and Autophagy via the ROS\/Akt Signaling Pathway in Human Follicular Thyroid Cancer Cells. Int J Mol Sci. 2023;24:8048.","journal-title":"Int J Mol Sci"},{"key":"2263_CR293","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.3390\/ijms24043418","volume":"24","author":"J Xie","year":"2023","unstructured":"Xie J, Liu J, Zhao M, Li X, Wang Y, Zhao Y, et al. Disulfiram\/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK\/ERK and PI3K\/AKT Pathways. Int J Mol Sci. 2023;24:3418.","journal-title":"Int J Mol Sci"},{"key":"2263_CR294","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12020-022-03124-6","volume":"78","author":"S-S Huang","year":"2022","unstructured":"Huang S-S, Tsai C-H, Kuo C-Y, Li Y-S, Cheng S-P. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells. Endocrine. 2022;78:85\u201394.","journal-title":"Endocrine"},{"key":"2263_CR295","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2174\/1871520622666220215123620","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Sun Q, Chen S, Yu X, Jing H. Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respiration and AMPK\/mTOR Signaling. Anticancer Agents Med Chem. 2022;22:2539\u201347.","journal-title":"Anticancer Agents Med Chem"},{"key":"2263_CR296","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1039\/C8BM01414K","volume":"7","author":"W Wang","year":"2019","unstructured":"Wang W, Liu J, Feng W, Du S, Ge R, Li J, et al. Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy. Biomater Sci. 2019;7:1052\u201363.","journal-title":"Biomater Sci"},{"key":"2263_CR297","doi-asserted-by":"crossref","unstructured":"Y H, Q W, Y C, Y L, W M, Q L, et al. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway. Phytomedicine Int J Phytother Phytopharm [Internet]. 2023 [cited 2024 Apr 7];108. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36343549\/","DOI":"10.1016\/j.phymed.2022.154528"},{"key":"2263_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105669","volume":"93","author":"L Zhang","year":"2023","unstructured":"Zhang L, Qiu L, Xu S, Cheng X, Wu J, Wang Y, et al. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment. Toxicol Vitro Int J Publ Assoc BIBRA. 2023;93: 105669.","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"},{"key":"2263_CR299","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.3390\/cancers14194568","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Q, Huang Z, Li B, Nice EC, Huang C, et al. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies. Cancers. 2022;14:4568.","journal-title":"Cancers"},{"key":"2263_CR300","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.708248","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, Gong Z, Liu Z, Wei M, Xue L, Vlantis AC, et al. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer. Front Endocrinol. 2021;12: 708248.","journal-title":"Front Endocrinol"},{"key":"2263_CR301","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2015.10.005","volume":"419","author":"MJ Jeon","year":"2016","unstructured":"Jeon MJ, Kim WG, Lim S, Choi H-J, Sim S, Kim TY, et al. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells. Mol Cell Endocrinol. 2016;419:113\u201323.","journal-title":"Mol Cell Endocrinol"},{"key":"2263_CR302","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/febs.16803","volume":"291","author":"X Li","year":"2024","unstructured":"Li X, Zhang H-S. Amino acid metabolism, redox balance and epigenetic regulation in cancer. FEBS J. 2024;291:412\u201329.","journal-title":"FEBS J"},{"key":"2263_CR303","doi-asserted-by":"crossref","unstructured":"Dabravolski SA, Nikiforov NG, Zhuravlev AD, Orekhov NA, Mikhaleva LM, Orekhov AN. The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment. Int J Mol Sci [Internet]. 2022 [cited 2023 Dec 4];23. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8745127\/","DOI":"10.3390\/ijms23010460"},{"key":"2263_CR304","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Gago S, Vicente-Guti\u00e9rrez J, Ruiz-Rodr\u00edguez JM, Calafell J, \u00c1lvarez-\u00c1lvarez A, Lasa M, et al. Autophagy sustains mitochondrial respiration and determines resistance to BRAFV600E inhibition in thyroid carcinoma cells. Autophagy. 2024;1\u201315.","DOI":"10.1080\/15548627.2024.2312790"},{"key":"2263_CR305","doi-asserted-by":"crossref","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227\u201332.","DOI":"10.1038\/nrc3483"},{"key":"2263_CR306","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2023.0560","volume":"34","author":"P Brock","year":"2024","unstructured":"Brock P, Sevigny M, Liyanarachchi S, Comiskey DF, Li W, Saarinen S, et al. PDPR Gene Variants Predisposing to Papillary Thyroid Cancer. Thyroid Off J Am Thyroid Assoc. 2024;34:575\u201382.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"2263_CR307","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, Montoya-Durango DE, Hu X, Yang C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040\u20132058.e10.","journal-title":"Cell Metab"},{"key":"2263_CR308","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, et al. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Ther. 2024;9:236.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02263-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:55:51Z","timestamp":1741712151000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":308,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02263-4","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}